CLC Number:
| [1] Baskin Jr HJ. The pathogenesis and imaging of the tuberous sclerosis complex[J]. Pediatr Radiol, 2008, 38(9): 936-952. [2] Amin S, Kingswood JC, Bolton PF, et al. The UK guidelines for management and surveillance of Tuberous Sclerosis Complex[J]. QJM, 2019, 112(3): 171-182. [3] Huang J, Manning BD. The TSC1-TSC2 complex:a molecular switchboard controlling cell growth[J]. Biochem J, 2008, 412(2): 179-190. [4] Johnson SR. Lymphangioleiomyomatosis[J]. Eur Respir J, 2006, 27(5): 1056-1065. [5] Logginidou H, Ao X, Russo I, et al. Frequent estrogen and progesterone receptor immunoreactivity in renal angiomyolipomas from women with pulmonary lymphangioleiomyomatosis[J]. Chest, 2000, 117(1): 25-30. [6] Lim KE, Tsai YH, Hsu YYl, et al. Pulmonary lymphangioleiomyomatosis. High-resolution CT findings in 11 patients and compared with the literature[J]. Clin Imaging, 2004, 28(1): 1-5. [7] Lee KC, Kang EY, Yong HS, et al. A stepwise diagnostic approach to cystic lung diseases for radiologists[J]. Korean J Radiol, 2019, 20(9): 1368-1380. [8] 胡晓文, 徐凯峰. 美国胸科协会和日本呼吸学会淋巴管肌瘤病2017年临床指南简介[J].中华结核和呼吸杂志, 2019(2): 98-100. doi: 10.3760/cma.j.issn.1001-0939.2019.02.004. [9] 郭生红, 李薇, 张谊芝, 结节性硬化症2例报道并文献复习[J].中国中西医结合皮肤性病学杂志,2020, 19(6): 594-595. [10] Northrup H, Krueger DA, International Tuberous Sclerosis Complex Consensus Group. Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 Iinternational Tuberous Sclerosis Complex Consensus Conference[J]. Pediatr Neurol, 2013, 49(4): 243-254. [11] Randle SC. Tuberous sclerosis complex: a review[J]. Pediatr Ann, 2017, 46(4): e166-e171. [12] Franz DN, Krueger DA. mTOR inhibitor therapy as a disease modifying therapy for tuberous sclerosis complex[J]. Am J Med Genet C Semin Med Genet, 2018, 178(3): 365-373. [13] McCormack FX, Inoue Y, Moss J, et al. Efficacy and safety of sirolimus in lymphangioleiomyomatosis[J]. N Engl J Med, 2011, 364(17): 1595-1606. [14] Hu S, Wu X, Xu W, et al. Long-term efficacy and safety of sirolimus therapy in patients with lymphangioleiomyomatosis[J]. Orphanet J Rare Dis, 2019, 14(1): 206. doi: 10.1186/s13023-019-1178-2. |
| [1] | . [J]. Journal of Shandong University (Health Sciences), 2022, 60(11): 127-129. |
| [2] | WANG Guangjie, ZU Shulu, ZHANG Xiulin, XU Zhishun, ZHOU Chunwen, LIU Yuqiang, WANG Shaoyong. Von Hippel-Lindau disease complicated with renal carcinoma: a report of 2 cases [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(2): 86-89. |
|
